1. Home
  2. CTS vs NEO Comparison

CTS vs NEO Comparison

Compare CTS & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTS
  • NEO
  • Stock Information
  • Founded
  • CTS 1896
  • NEO 2001
  • Country
  • CTS United States
  • NEO United States
  • Employees
  • CTS N/A
  • NEO N/A
  • Industry
  • CTS Electrical Products
  • NEO Precision Instruments
  • Sector
  • CTS Technology
  • NEO Health Care
  • Exchange
  • CTS Nasdaq
  • NEO Nasdaq
  • Market Cap
  • CTS 1.2B
  • NEO 1.1B
  • IPO Year
  • CTS N/A
  • NEO 1999
  • Fundamental
  • Price
  • CTS $38.21
  • NEO $9.11
  • Analyst Decision
  • CTS
  • NEO Buy
  • Analyst Count
  • CTS 0
  • NEO 10
  • Target Price
  • CTS N/A
  • NEO $12.56
  • AVG Volume (30 Days)
  • CTS 186.0K
  • NEO 2.9M
  • Earning Date
  • CTS 10-28-2025
  • NEO 10-28-2025
  • Dividend Yield
  • CTS 0.42%
  • NEO N/A
  • EPS Growth
  • CTS 18.55
  • NEO N/A
  • EPS
  • CTS 2.11
  • NEO N/A
  • Revenue
  • CTS $520,937,000.00
  • NEO $689,189,000.00
  • Revenue This Year
  • CTS $4.41
  • NEO $10.40
  • Revenue Next Year
  • CTS $7.00
  • NEO $10.11
  • P/E Ratio
  • CTS $18.22
  • NEO N/A
  • Revenue Growth
  • CTS 1.12
  • NEO 9.70
  • 52 Week Low
  • CTS $34.02
  • NEO $4.72
  • 52 Week High
  • CTS $59.68
  • NEO $19.12
  • Technical
  • Relative Strength Index (RSI)
  • CTS 34.94
  • NEO 67.10
  • Support Level
  • CTS $39.26
  • NEO $7.56
  • Resistance Level
  • CTS $40.63
  • NEO $8.01
  • Average True Range (ATR)
  • CTS 1.10
  • NEO 0.38
  • MACD
  • CTS -0.22
  • NEO 0.06
  • Stochastic Oscillator
  • CTS 0.65
  • NEO 92.86

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: